ArthroCare (ARTC) Misses Q4 Views
Tweet
Share
E-mailGet Alerts ARTC Hot Sheet
Join SI Premium – FREE
ArthroCare (NASDAQ: ARTC) reported Q4 EPS of ($1.06), $1.26 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $92.4 million versus the consensus estimate of $97.47 million.
For earnings history and earnings-related data on ArthroCare (ARTC) click here.
For earnings history and earnings-related data on ArthroCare (ARTC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
- DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
